Hepatitis C Among Opioid Addicts in Opioid Maintenance Treatment in Zurich, Switzerland

Hepatitis C Bei Opioidabhängigen in Der Praxis, Eine Querschnittsuntersuchung

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00473993

Acronym

HepCOP

Enrollment

Unknown

Registered

2007-05-16

Start date

2007-07-31

Completion date

2007-12-31

Last updated

2009-02-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatitis C, Chronic, Opioid-Related Disorders, Substance Abuse Treatment Centers

Keywords

Hepatitis C, Opioid Maintenance Treatment, Methadone, Buprenorphine, Heroin, Interferon, pegylated

Brief summary

Hepatitis C viral infection is common among opioid addicts in Zurich, Switzerland. The majority undergoes a maintenance treatment with methadone, heroin or buprenorphine. While stabilized by an opioid maintenance treatment (OMT)chronic hepatitis C can be treated with pegylated interferon plus ribavirin. As not sufficiently known, the results are comparable to the results of the treatment of nonaddicts. Our crossectional study investigates how many patients undergoing OMT are adequately investigated concerning hepatitis C. If not, why are they not adequately investigated and treated? Representative data are collected in the local clinics and medical practices involved in OMT in the Kanton of Zurich. The patients files are revised and the involved doctors are asked through a structured interview.

Detailed description

www.seidenberg.ch/hepcop.pdf

Interventions

None listed

Study design

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

* Medical practices and clinics involved in opioid maintenance treatment in the Kanton of Zurich, Switzerland

Outcome results